Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Leila, Sabour Takanlou"'
Autor:
Fatemeh Sadeghsoltani, Çığır Biray Avci, Parisa Hassanpour, Sanya Haiaty, Mohamad Rahmati, Ali Mota, Reza Rahbarghazi, Maryam Nemati, Mahdi Mahdipour, Mehdi Talebi, Leila Sabour Takanlou, Maryam Sabour Takanlou, Amir Mehdizadeh
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Background Recent studies have proved the role of autophagy in mesenchymal stem cell (MSCs) function and regenerative properties. How and by which mechanism autophagy modulation can affect the juxtacrine interaction of MSCs should be address
Externí odkaz:
https://doaj.org/article/4dac3b1eb6294da7bb5cf76904c2bcd2
Autor:
Cigir Biray Avci, Bakiye Goker Bagca, Masoud Nikanfar, Leila Sabour Takanlou, Maryam Sabour Takanlou, Alireza Nourazarian
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
The tumor microenvironment (TME) plays a crucial role in cancer development and metastasis. This review summarizes the current research on how the TME promotes metastasis through molecular pathways, focusing on key components, such as cancer-associat
Externí odkaz:
https://doaj.org/article/6413023622c646bea4fe6a5cb47eab51
Autor:
Cigir Biray Avci, Bakiye Goker Bagca, Behrouz Shademan, Leila Sabour Takanlou, Maryam Sabour Takanlou, Alireza Nourazarian
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Cancer therapy is on the brink of a significant transformation with the inclusion of patient-derived organoids (PDOs) in drug development. These three-dimensional cell cultures, directly derived from a patient’s tumor, accurately replicate the comp
Externí odkaz:
https://doaj.org/article/19e3a26eab074868af1705be2ed26c68
Correlation between Ubiquitin E3 Ligases (SIAHs) and Heat Shock Protein 90 in Breast Cancer Patients
Autor:
Leila Sabour Takanlou, Gulsah Cecener, Maryam Sabour Takanlou, Hulya Ozturk Nazlioglu, Havva Tezcan Unlu, Ozgen Isik, Unal Egeli, Berrin Tunca, Erdem Cubukcu, Sahsine Tolunay, Mustafa Sehsuvar Gokgoz
Publikováno v:
Iranian Journal of Public Health, Vol 51, Iss 8 (2022)
Background: Breast cancer is a heterogeneous disease and differences in the expression levels of the ER, PR, and HER2 the triplet of established biomarkers used for clinical decision-making have been reported among breast cancer patients. Furthermore
Externí odkaz:
https://doaj.org/article/a7e0c5d247564e079a36c1c42e000b3d
Autor:
Maryam SABOUR TAKANLOU, Seyed Ali RAHMANI, Yadollah AHMADI ASR BADR, Mehrdad PASHAZADEH, Leila SABOUR TAKANLOU
Publikováno v:
Iranian Journal of Public Health, Vol 49, Iss 7 (2020)
N A
Externí odkaz:
https://doaj.org/article/a22651057f8c4a96a3fc554138d882dd
Autor:
Furkan Sarıdaş, Mehmet Zarifoglu, Havva Tezcan Unlu, Gulsah Cecener, Unal Egeli, Ömer Faruk Turan, Berrin Tunca, Maryam Sabour Takanlou, Leila Sabour Takanlou, Ozlem Taskapilioglu
Publikováno v:
Neurological Research. 44:217-223
Multiple sclerosis (MS) is an inflammatory, autoimmune demyelinating, and neurodegenerative disorder of the central nervous system. Interactions between environmental factors, predisposition genes, and determining genes appear to be involved in its e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b9f4e093d9f03669e3ceeb3e2b1b412
https://doi.org/10.1080/01616412.2021.1975221
https://doi.org/10.1080/01616412.2021.1975221
Autor:
Leila Sabour Takanlou, Buket Özel, Cumhur Gündüz, Maryam Sabour Takanlou, Cigir Biray Avci, Sezgi Kipcak, Nur Selvi Günel
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 21:1724-1731
Background: Chronic Myeloid Leukemia (CML) is characterized by a reciprocal translocation t(9;22) and forms BCR/ABL1 fusion gene called the Philadelphia chromosome. The therapeutic targets for CML patients mediated with BCR/ABL1 oncogenic are tyrosin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2839948407b8004cbebae2fb16c3898c
https://doi.org/10.2174/1871520620666201106085929
https://doi.org/10.2174/1871520620666201106085929
Publikováno v:
Gene. 869:147390
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdabbd4c597dcb8d1654d40fa3c11d08
https://doi.org/10.1016/j.gene.2023.147390
https://doi.org/10.1016/j.gene.2023.147390
Autor:
Ismet Tasdelen, Ufuk Unal, Gamze Guney Eskiler, Erdem Cubukcu, Sibel Kahraman Çetintaş, Mustafa Sehsuvar Gokgoz, Havva Tezcan, Gulsah Cecener, Secil Ak Aksoy, Berrin Tunca, Maryam Sabour Takanlou, Unal Egeli, Turkkan Evrensel, Leila Sabour Takanlou, Isil Ezgi Eryilmaz
Publikováno v:
Cancer Genetics. 240:23-32
The aim of this study was to identify the frequency and spectrum of germline BRCA1/2 pathogenic alterations in a cohort of patients with breast carcinoma. In this study, a total of 603 breast cancer subjects from Turkey were screened for BRCA1/BRCA2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b30ef1c892a5a2eb8f1b31fe8531dd85
https://doi.org/10.1016/j.cancergen.2019.10.004
https://doi.org/10.1016/j.cancergen.2019.10.004
Autor:
Buket Ozel, Sezgi Kipcak, Cigir Biray Avci, Maryam Sabour Takanlou, Leila Sabour Takanlou, Burcin Tezcanli Kaymaz, Ilknur Karatekin, Cumhur Gunduz, Nur Selvi Gunel
Publikováno v:
Medical oncology (Northwood, London, England). 39(9)
Chronic myeloid leukemia (CML) is a myeloproliferative disease that mediated by BCR/ABL oncogenic signaling. CML can be targeted with the imatinib, dasatinib, and nilotinib TKI inhibitors, the latter two of them have been approved for imatinib-resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cadf5d098ae65edb94485230377465
https://pubmed.ncbi.nlm.nih.gov/35716222
https://pubmed.ncbi.nlm.nih.gov/35716222